Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating peripheral stem cell transplantation in adults with multiple myelo…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment [Phase 1]
Phase 1 trial of the agent 506U78 in patients with hematologic cancers and kidney or liver impairment; the study has terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Update on a clinical trial evaluating umbilical cord blood stem cell transplant for leukemia, lymphoma, and other hematologic conditions. Th…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a regimen of bortezomib, pegylated liposomal doxorubicin (Doxil), and dexamethasone, with or without thali…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide plus rituximab in patients with recurrent or refractory multiple myeloma; the study was terminated wit…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of lenalidomide in combination with vaccine therapy for relapsed or refractory multiple myeloma has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating the combination of rituximab and cyclophosphamide in patients with high-risk, refractory, or relapsed mult…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: PAD. ICORG 05-01, V11 [Phase 2]
Phase 2 trial ICORG 05-01 for multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy [Phase 1]
Phase 1 safety study of CLT-008 human myeloid progenitor cells after cord blood transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without thalidomide in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial of brostallicin for recurrent or refractory multiple myeloma and related plasma cell neoplasms has completed enroll…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating a combination of liposomal doxorubicin, melphalan, and bortezomib in…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without oblimersen for relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for patients with multiple myeloma and other B-cell cancers, including…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
This ClinicalTrials.gov entry reports a Phase 2 trial evaluating the combination of chemotherapy and peripheral stem cell transplantation in…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [Phase 3]
An update on a Phase 3 trial evaluating combination chemotherapy with or without cyclophosphamide and prednisone in older patients with mult…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [Phase 3]
Phase 3 trial evaluating the addition of interferon alfa to chemotherapy, with or without bone marrow or peripheral stem cell transplantatio…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating whether adding Wobe-Mugos E to chemotherapy improves outcomes in stage II/III multiple myeloma; current status is…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Myeloma [Phase 1, Phase 2]
Clinical trial update on Beta Alethine for treating multiple myeloma and related plasma cell neoplasms, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
A terminated clinical trial studied T cells in blood and bone marrow from patients with multiple myeloma, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy given after GM-CSF for treating multiple myeloma; the study status is completed.